Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 50 2005 004 948.9 |
96 | EP file number | EAKZ | 05 09 0214.7 |
97 | EP publication number | EPN | 1746101 |
54 | Designation/title | TI | Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen |
51 | IPC main class | ICM (ICMV) | C07J 53/00 (2006.01) |
22 | DE application date | DAT | Jul 21, 2005 |
96 | EP application date | EAT | Jul 21, 2005 |
43 | Date of first publication | OT | Jan 24, 2007 |
| Date of publication of grant | PET | Aug 6, 2008 |
71/73 | Applicant/owner | INH | Bayer Pharma Aktiengesellschaft, 13353 Berlin, DE |
72 | Inventor | IN | Seilz, Carsten, 59199 Bönen, DE; Seba, Hartmut, 59423 Unna, DE |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | DE - Deutsch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001746101 Searchable text:
EP000001746101 Original document:
EP000001746101B1 Searchable text:
EP000001746101B1 |
43 | Date of first publication | EVT | Jan 24, 2007 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 25, 2024 (Show all update days)(Hide all update days)- Apr 25, 2024; Mar 19, 2024; Jul 7, 2022; Apr 30, 2022; Jun 25, 2021; Jul 10, 2020; Aug 9, 2019; Jul 24, 2019; Jul 27, 2018; Aug 2, 2017; Jul 21, 2016; Jul 25, 2015; Aug 7, 2014; Aug 6, 2014; Jul 29, 2014; Jun 18, 2014; May 14, 2014; Aug 8, 2013; Aug 2, 2013; Jan 29, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|